Sri Lotus Developers IPO Allotment Status: The real estate company has announced its allotment status for the Rs 792 crore worth IPO. Sri Lotus is among the top IPOs that will list on the BSE and NSE this week.






The current grey market premium (GMP) on August 5 is signaling a 26% premium listing on exchanges.
Sri Lotus Developers IPO Allotment Status:
There are three methods to check Sri Lotus Developers IPO allotment status online. These are BSE, NSE and the registrar of the IPO, KFin Technologies.
Sri Lotus Developers IPO Allotment Status On KFin Technologies:

 
Step 2: Select the IPO name 'Sri Lotus Developers & Realty Limited'.
Step 3: Enter either the application no, Demat account or PAN card number next.
Step 4: Fill in the captcha code in the required box. Then click on SUBMIT.
Sri Lotus Developers IPO Allotment Status On BSE:

 
Step 2: Select the issue type 'Equity'.
Step 3: Enter issue name 'Sri Lotus Developers & Realty Limited'.
Step 4: Enter either Application No or PAN Card number.
Step 5: Select the Search option lastly.
Sri Lotus Developers IPO Allotment Status On NSE:

 
Step 2: Select the issue type 'Equity & SME IPO Bid Details'.
Step 3: Select the issue symbol, which is 'LOTUSDEV'.
Step 4: Enter PAN card and Application number to take the process ahead.
Step 5: Select SUBMIT.
Sri Lotus Developers IPO GMP:
As per Investor Grain, Sri Lotus Developers IPO last GMP is Rs 39, last updated Aug 5th 2025 07:33 AM. With the price band of 150.00, Sri Lotus Developers IPO's estimated listing price is Rs 189 (cap price + August 5 GMP).The expected percentage gain/loss per share is 26.00%.
Sri Lotus Developers IPO Credit Of Shares:
The company is expected to initiate refund of bids or credit shares to eligible investors on August 5, 2025.
Sri Lotus Developers IPO Listing Date:
The tentative listing date Sri Lotus Developers IPO on BSE and NSE is likely to be on August 6, 2025.
According to Rajan Shinde, Research Analyst, Mehta Equities, on valuation parse at the upper price band of Rs 150/-, the issue is asking for a market cap of Rs 7331 crore. Based on FY 2025 earnings and fully-diluted post-IPO paid-up capital, the company is asking for a PE 32.17x which seems fully priced relative to its future growth prospects. With 5 ongoing and 11 upcoming projects across key micro-markets in Mumbai-alongside strategic expansion into high-value localities such as Prabhadevi, Nepean Sea Road, and Bandra-Company is well-positioned to capitalize on sustained urban housing demand and rising premium real estate prices. Operating in a highly competitive and fragmented market, the company stands out as a niche ultra-luxury developer with high margins, though it comes to market at a premium valuation. The presence of notable investors and Bollywood personalities in the pre-IPO placement adds visibility but also elevates expectations.
Sri Lotus Developers launched its IPO from July 30th to August 1st, at a price band of Rs 140 to Rs 150 per share. The IPO's issue price will be of Rs 150 per share. On the final day, the IPO received massive subscription of 69.14x.
 


Read more
Stock market today: Trade setup for Nifty 50, Trump tariffs, Q1 results today; 8 stocks to buy or sell on Tuesday
Khelja
Buy Suzlon stock, stay cautious on HAL & RVNL shares, suggests Anand Rathi
Khelja
‘Generational aura debt’: NASCAR racer Connor Zilisch on fall from car that broke collarbone
Khelja
Emma Raducanu knocked out of Cincinnati Open by Aryna Sabalenka
Khelja
Manchester Originals beat London Spirit to end Old Trafford losing run
Khelja
Bihar Weather Alert: Alert in Bihar due to heavy rains and thunderstorms, know where the danger. Bihar Heavy Rain Alert Supaul Araria Purnia Orange Alert 12 August 2025
Khelja
US: Plane Crashes Into Another While Landing In Montana; Shocking Visuals Of Fireball Emerge
Khelja
Mumbai-Thane Metro: Deputy CM Announces Launch Date for Last-Minute Commute Solution
Khelja
Transgender Power in Sports World: Know the Inspiring Story of 6 players | 6 transgender who played sport for their country
Khelja
Novartis Rides Bullish Retail Mood, Roche Faces Gloom Amid Swiss-US Trade Concerns
Khelja